LendPro and SPLICE Software Announce Strategic Partnership to Enhance Retail Financing Engagement
This collaboration integrates LendPro's multi-lender application waterfall system with SPLICE's Data-Driven Dialogs®, enabling retailers to deliver personalized, timely, and compliant customer communications across multiple channels. The joint solution empowers merchants to increase financing approvals, drive higher ticket sales, and enhance customer satisfaction through seamless, automated engagement.
'Our partnership with SPLICE Software represents a major advancement in how merchants can engage with their customers after the initial financing conversation. By combining LendPro's multi-lender application waterfall with SPLICE's intelligent communication platform, we are creating a powerful ecosystem where merchants don't just capture leads — they nurture them.' Said Matt Dishman CEO of LendPro
'Through this collaboration, merchants will now have the ability to drive Pre-Qualified Offers and Open-to-Buy financing opportunities back to the consumer — all tied directly to the original merchant who created the lead. This means merchants maintain ownership of their customer relationships, create more buying moments, and ultimately increase ticket sizes and lifetime value.'
'At LendPro, our goal has always been to empower merchants to serve more customers and close more sales. This partnership ensures that no opportunity is left behind — it brings financing full circle, from initial application to ongoing personalized engagement.'
'We are excited for what this means not only for our retailers, but for the future of embedded consumer financing and customer-centric marketing.'
'Our partnership with LendPro brings a new level of personalization and efficiency to retail financing communications,' said Tara Kelly, President & CEO of SPLICE Software. 'Our combined technologies will enable retailers to engage customers more effectively, fostering stronger relationships and driving business growth.'
Come visit us Furniture Market in the Resource Center booth #12
About LendPro
Founded in 2011, LendPro offers a cloud-based lending platform designed to facilitate consumer applications for retail finance programs. The company's platform enables consumers to apply for financing from multiple lender partners integrated into the Open-to-Buy ecosystem, covering a wide range of credit profiles. LendPro's solutions are utilized across various industries, including home furnishings, medical and dental, mobile electronics, automotive, and jewelry.
About SPLICE Software
SPLICE Software is a leading customer engagement company focused on insurance, retail, financial services, and healthcare. SPLICE's Data-Driven Dialogs® enable businesses to send proactive notifications and engage in two-way dialogues via their channels of choice, including text, chat, call, email, and voice-first, with full opt-in and opt-out management.
Media Contacts:
SPLICE Software
Email: [email protected]
403 720 - TEAM
LendPro
Email: [email protected]
Phone: (434) 202-0137
View original content: https://www.prnewswire.com/news-releases/lendpro-and-splice-software-announce-strategic-partnership-to-enhance-retail-financing-engagement-302438893.html
SOURCE SPLICE Software Inc
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNN
20 minutes ago
- CNN
Trump faces continued Epstein fallout and a tariffs deadline as he returns from his Scotland trip
We process your data to deliver content or advertisements and measure the delivery of such content or advertisements to extract insights about our website. We share this information with our partners on the basis of consent. You may exercise your right to consent, based on a specific purpose below or at a partner level in the link under each purpose. Some vendors may process your data based on their legitimate interests, which does not require your consent. You cannot object to tracking technologies placed to ensure security, prevent fraud, fix errors, or deliver and present advertising and content, and precise geolocation data and active scanning of device characteristics for identification may be used to support this purpose. This exception does not apply to targeted advertising. These choices will be signaled to our vendors participating in the Transparency and Consent Framework. The choices you make regarding the purposes and vendors listed in this notice are saved and stored locally on your device for a maximum duration of 1 year.
CNN
an hour ago
- CNN
Watch water pour over New York train
We process your data to deliver content or advertisements and measure the delivery of such content or advertisements to extract insights about our website. We share this information with our partners on the basis of consent. You may exercise your right to consent, based on a specific purpose below or at a partner level in the link under each purpose. Some vendors may process your data based on their legitimate interests, which does not require your consent. You cannot object to tracking technologies placed to ensure security, prevent fraud, fix errors, or deliver and present advertising and content, and precise geolocation data and active scanning of device characteristics for identification may be used to support this purpose. This exception does not apply to targeted advertising. These choices will be signaled to our vendors participating in the Transparency and Consent Framework. The choices you make regarding the purposes and vendors listed in this notice are saved and stored locally on your device for a maximum duration of 1 year.
Business Wire
2 hours ago
- Business Wire
KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
MAHWAH, N.J.--(BUSINESS WIRE)-- KORU Medical Systems, Inc. (NASDAQ: KRMD) ('KORU Medical' or the 'Company'), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced inducement equity awards to Adam Kalbermatten, Chief Commercial Officer, pursuant to his previously announced employment agreement with the Company dated as of June 30, 2025. Mr. Kalbermatten was granted nonqualified stock options on August 1, 2025 to purchase 600,000 shares of the Company's common stock at an exercise price of $3.44 per share. In addition, on July 28, 2025, his start date, Mr. Kalbermatten received 300,000 restricted shares of the Company's common stock. Each of these awards are subject to vesting 25% on each anniversary of their grant date, subject to accelerated vesting and the other terms and conditions of the respective award agreements entered into between Mr. Kalbermatten and the Company. The Compensation Committee of the Company's Board of Directors approved the awards as an inducement material to Mr. Kalbermatten's employment in accordance with Nasdaq Listing Rule 5635(c)(4). About KORU Medical Systems KORU Medical Systems develops, manufactures, and commercializes innovative and patient-centric large volume subcutaneous infusion solutions that improve quality of life for patients around the world. The Freedom Syringe Infusion System (the 'Freedom System') currently includes the Freedom60® and FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing™ and HigH-Flo Subcutaneous Safety Needle Sets™. The Freedom System, which received its first FDA clearance in 1994, is used for self-administration in the home by the patient and/or delivery in an ambulatory infusion center by a healthcare professional. Through its Pharma Services and Clinical Trials business, KORU Medical provides products for use by biopharmaceutical companies in feasibility/clinical trials during the drug development process and, as needed, is capable of customizing the Freedom System for clinical and commercial use across multiple drug categories. For more information, please visit
